Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionPotassium channel blocker
Molecular Target Potassium channel
Mechanism of ActionK channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSleep apnea
Indication DetailsTreat obstructive sleep apnea (nasal route)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today